Camino Inka
Top PDF Camino Inka:
Experimental model for graft -versus-host disease in rat limb allotransplantation
... Graft versus-host disease (GVHD) is a potentially fatal immune-regulated injury occurring unpredictably in solid organ and bone marrow transplant ...
Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.
... malignant disease itself GVHD is the most common cause of death for patients who have undergone stem cell transplantation ...for disease control [10, ...
Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation
... Acute graft-versus-host disease (aGVHD) and infec- tion/reactivation of cytomegalovirus (CMV) are among the most frequent and important complications after allogeneic hematopoietic stem cell ...
The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host disease.
... as graft rejection and graft-versus-host ...acute graft- versus-host ...acute graft-versus-host ...acute graft-versus- host ...
Chronic graft-versus-host disease : a risk factor for secondary malignancies after allogeneic stem-cell transplant
... chronic graft-versus-host disease and secondary ...chronic graft-versus-host disease and its treatment have been implied as potential risk factors for secondary ...
Etanercept on steroid-refractary acute graft-versus-host disease
... In four cases etanercept 25mg was administered twice a week with variable duration of treatment, achieving no response in 1 case (3 weeks), partial response in two 2 cases (4 weeks and 8 weeks) and a complete response in ...
Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
... acute graft-versus-host disease (aGVHD) is a life-threatening complication associated with HLA mis- match, high recipient age, low marrow cell dose, and splenectomy [2, ...
Chronic graft-versus-host disease: clinical presentation of multiple lesions of lichenoid and atrophic pattern
... The graft-versus-host disease (GVHD) is an immune-mediated syndrome expressed by cutaneous or cutaneous / systemic signals and symptoms, main- ly in recipients of allogeneic stem cells or bone ...
Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation
... The purpose of the present study was to evaluate the mixed lympho- cyte culture as a predictive assay of acute and chronic graft-versus- host disease (GVHD). We studied 153 patients who ...
Less graft-versus-host disease after rabbit antithymocyte globulin conditioning in unrelated bone marrow transplantation for leukemia and myelodysplasia: comparison with matched related bone marrow transplantation.
... One of the major drawbacks for unrelated donor (UD) bone marrow transplantation (BMT) is graft-versus-host disease (GVHD). Despite results from randomized trials, antithymocyte globulin (ATG) ...
Graft-versus-host disease: a surge of developments.
... benefi cial graft-versus-tumor (GVT) response but also resulting in possibly life-threatening graft-versus-host disease (GVHD). The manifestations of GVHD vary over its course. ...
Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine
... TA-GVHD usually occurs in immunosuppressive and immunodeficient patients. The pathogenesis and mechanism of TA-GVHD are complex and likely similar to GVHD in patients who have undergone bone marrow transplantation. ...
Treatment of Vaginal Agglutination Complicating Chronic Graft-Versus-Host Disease: A Rare Case Report
... 8. Hundley AF, Magro C, Bartholomew D. Vaginal agglutination: chronic grat- versus-host disease mimics lichen planus. J Low Genit Tract Dis 2011;15(1):71-4. 9. Costantini S, Di Capua E, Bosi S, ...
Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.
... malignant disease prior to allo-HSCT (chemotherapy, n = 21; monoclonal antibodies, n = 8; autologous HSCT, n = 9; irradia- tion, n = 4; cytokine therapy, n = ...
Chronic graft-versus-host disease : second line therapy review
... 27 already been made. First of all, ECP does not treat cGVHD by destroying every single leucocyte responsible for the reaction, because of the simple fact that not all of these cells are in fact exposed do the radiation ...
Einstein (São Paulo) vol.12 número2
... chronic graft-versus-host disease, based on the histopathologic classification of the National Institutes of Health and correlate them with clinical ...chronic ...
Einstein (São Paulo) vol.11 número2
... Human interleukin 17 was first described in 1995 as a new cytokine produced primarily by activated T CD4+ cells that stimulate the secretion of IL-6 and IL-8 by human fibroblasts, besides increasing the expression of ...
Chimerism induction by nonmyeloablactive preconditioning and bone marrow infusion in rat small bowel transplantation
... The inability to achieve a stable chimeric state did not allow us to determine the effect of chimerism on graft and recipient survival after small bowel transplan- tation. Based on this background, we are trying ...
Clinics vol.65 número11
... acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical ...
Diretrizes para o diagnóstico, classificação, profilaxia e tratamento da doença enxerto contra hospedeiro crônica.
... plante de medula óssea:tratamento com psoraleno e ultravioleta A. Dissertação (Mestrado em Hematologia). Faculdade de Medici- na, Universidade Federal do Rio de Janeiro. Rio de Janeiro, 1996. 77. Bouzas LFS, Ferman S, ...